Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
about
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementProteomic Approaches to Biomarker Discovery in Cutaneous T-Cell LymphomaAnomalous constitutive Src kinase activity promotes B lymphoma survival and growth.IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosisProgrammed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphomaEctopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaBakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinaseBacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Elucidating the role of interleukin-17F in cutaneous T-cell lymphomaNew developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.miRNA in mycosis fungoides and skin inflammation.NFκB function and regulation in cutaneous T-cell lymphoma.Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.A novel BLK-induced tumor model.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaVascular endothelial growth factor receptor-3 expression in mycosis fungoides.Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomainDose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).Mycosis fungoides progression could be regulated by microRNAs.
P2860
Q24629558-73164DA9-FE8D-4816-A5DA-9749FA671CC0Q27024076-70121F6B-3A5E-468A-809D-91C0D4682399Q28071331-8D47E069-6713-405B-BBE7-F5F0A9C87260Q33623874-7B6BD3D1-31BF-4D05-9F88-B0204597B920Q33728396-2F85BA23-9A74-4190-9694-746F9737D02EQ34100988-3656D68F-79C7-49E2-B214-0D49459820BAQ34154516-0C7F536A-6606-46D7-B9F4-7F160AA4472FQ35201911-D8FE0513-D676-44E6-A11A-92536DB76B6EQ35987358-C882D8C7-0115-4248-820B-CFD4707CFDF4Q36142098-D4268133-9A85-4B07-8107-D9C1604D273CQ36470196-837488CE-164D-485C-BA6E-0E263A14A5F1Q36675064-F5BB7271-7347-488F-898D-C01E7CB37893Q37046675-148D31F4-7FF5-4A75-AD6E-8C56ED809E83Q37139517-905C86B5-4446-4916-83E2-E838A998F54DQ37216178-E2664045-5D26-436C-849C-F0619C71584BQ37716643-8326D0D7-E5C6-4F5C-AFC2-C6F190C016FCQ37929548-130E2507-57F6-40B9-AAF4-E527995953D6Q37944565-28ACCD28-21E1-4CA9-B1DB-0BD38DC62A28Q38150868-0B507846-2360-43B8-9F68-5DEDB86742E1Q38162229-355BDE32-39C9-4A9B-9AA7-B79ACFC9DEFCQ38223605-B67C13BC-4351-4067-B03D-0534629965AAQ38698300-306EB04F-826F-4835-BAAA-C7332DA509F4Q38846167-97124149-AFCF-4ADE-BE5C-20AA69F067A0Q39285766-A535ED4D-4262-4063-A5C9-886EFEB105DFQ40150337-9C0F9F8E-304F-4DD9-9E44-2252C1B25A14Q42690539-14A6D208-3210-4D2E-B81F-05419AE17E1BQ42921947-17E13839-233C-4D20-A5DB-4DD6F301A64FQ42936107-A4294F3D-35C1-43FA-A1C2-FFF41C7008BEQ53299556-8F454EB5-F0FE-4143-9C7A-994112098EA4Q55407685-8D6583B7-08C2-4D7E-9C48-0E5D61332B95
P2860
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@en
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@nl
type
label
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@en
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@nl
prefLabel
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@en
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@nl
P2093
P2860
P50
P1433
P1476
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
@en
P2093
Claudia S Vetter-Kauczok
Elisabeth Ralfkiaer
Hermann Kneitz
Juergen C Becker
Karsten W Eriksen
Mariusz A Wasik
Niels Ødum
Paola Lovato
Qian Zhang
Thorbjørn Krejsgaard
P2860
P304
P356
10.1182/BLOOD-2008-09-181024
P407
P577
2009-04-07T00:00:00Z